News

AstraZeneca (LSE:AZN) recently launched "FluMist Home," an at-home flu vaccine delivery service, marking an important ...
The government is partnering with the local subsidiary of multinational pharmaceutical company AstraZeneca to develop the ...
AstraZeneca PLC released its flu vaccine nasal spray for at-home use on Friday, an option that comes at a contentious time ...
AstraZeneca PLC closed 12.32% short of its 52-week high of £133.88, which the company achieved on September 3rd.
Starting Friday, Americans can order the nasal spray flu vaccine online and have it shipped directly to their home.
AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...
The treatment is one for those suffering with lung cancer who never smoked, a group of patients who account for up to 25% of ...
Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a transformational leader at the pharmaceutical giant.
The Philippine Economic Zone Authority (Peza) has sealed a deal with AstraZeneca Pharmaceuticals (Phils.) to establish the country’s first pharma innovation hub, a flagship project aimed at boosting ...
He said about Britain that the firm needed “to see that there is access and a reason to invest.” This is partly a negotiating tactic to get a better deal from the British government, including on what ...
A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on Friday.
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...